Scarica l'app Stockscreener
20.41
0.34%
0.07
Dopo l'orario di chiusura:
20.41
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ZLAB Giù?
Forum
Previsione
Zai Lab Limited Adr Borsa (ZLAB) Ultime notizie
Yajing Chen Sells 5,199 Shares of Zai Lab (NASDAQ:ZLAB) Stock - defenseworld.net
Zai Lab Limited And Amgen Inc. Collaborate To Advance DLL3 Targeted Combination Therapy In Small Cell Lung Cancer - BioPharma APAC
Zai Lab Limited (9688.HK) stock price, news, quote and history - Yahoo Finance Singapore
Zai Lab Limited (ZLAB) Stock Price, News, Quote & History - Yahoo! Finance Canada
Zai Lab Limited (ZLAB) stock price, news, quote and history - Yahoo Finance Singapore
Revenue per share of Zai Lab Ltd. Sponsored ADR – FWB:1ZL - TradingView
Zai Lab (NASDAQ:ZLAB) CFO Sells $106,007.61 in Stock - MarketBeat
Zai Lab (NASDAQ:ZLAB) Insider Sells $196,029.46 in Stock - MarketBeat
Zai Lab (NASDAQ:ZLAB) CEO Ying Du Sells 5,576 Shares - MarketBeat
Rafael Amado Sells 9,910 Shares of Zai Lab (NASDAQ:ZLAB) Stock - MarketBeat
Zai Lab (ZLAB) executive sells ADSs to cover tax after RSU vest - Stock Titan
Zai Lab Ltd (ADR) stock: China's biotech powerhouse eyes global gains - AD HOC NEWS
Zai Lab (ZLAB) CLO nets ADSs after RSU vesting and tax sale - Stock Titan
[144] Zai Lab Ltd SEC Filing - Stock Titan
Rafael Amado reports ADS sales for ZLAB (NASDAQ: ZLAB) - Stock Titan
9,614 ADS tied to vesting listed by ZLAB (NASDAQ: ZLAB) with Fidelity broker - Stock Titan
Insider sells ZLAB (NASDAQ: ZLAB) ADS — Form 144 lists 4,194 shares - Stock Titan
Affiliate sale notice: ZLAB (NASDAQ: ZLAB) up to 5,199 ADS - Stock Titan
Zai Lab (NASDAQ:ZLAB) Trading 9.5% HigherStill a Buy? - MarketBeat
Zai Lab Announces Global Clinical Trial Collaboration and Supply Agreement to Evaluate Novel DLL3 ADC, Zocilurtatug Pelitecan, in Combination with a Bispecific T-cell Engager Therapy - ChartMill
KeyCorp (NYSE:KEY) Price Target Cut to $24.00 by Analysts at Morgan Stanley - Defense World
Hesai Group Sponsored ADR (NASDAQ:HSAI) Given Consensus Rating of “Buy” by Brokerages - Defense World
Hennes & Mauritz AB (OTCMKTS:HNNMY) Given Average Recommendation of “Hold” by Brokerages - Defense World
HBT Financial, Inc. (NASDAQ:HBT) Receives Consensus Recommendation of “Moderate Buy” from Brokerages - Defense World
Journey Medical Corporation (NASDAQ:DERM) Given Consensus Rating of “Hold” by Analysts - Defense World
NeuroPace, Inc. (NASDAQ:NPCE) Receives Consensus Rating of “Moderate Buy” from Brokerages - Defense World
BTC Capital Management Inc. Lowers Holdings in Verizon Communications Inc. $VZ - Defense World
Constellation Software Inc. (OTCMKTS:CNSWF) Receives Average Recommendation of “Moderate Buy” from Brokerages - Defense World
The Goldman Sachs Group Issues Positive Forecast for Bicara Therapeutics (NASDAQ:BCAX) Stock Price - Defense World
KANZHUN LIMITED Sponsored ADR (NASDAQ:BZ) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
Precision Drilling Corporation (NYSE:PDS) Receives Average Rating of “Moderate Buy” from Analysts - Defense World
Grupo Televisa S.A. (NYSE:TV) Receives Average Recommendation of “Hold” from Brokerages - Defense World
Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB) Sees Large Growth in Short Interest - MarketBeat
Zai Lab (NASDAQ:ZLAB) Shares Gap UpShould You Buy? - MarketBeat
Zai Lab (09688.HK) Narrows Loss to USD176 Million Last Year - AASTOCKS.com
Virtus Biotech ETF Holdings - Quiver Quantitative
Richard Gaynor Acquires 1,731 Shares of Zai Lab (NASDAQ:ZLAB) Stock - MarketBeat
Zai Lab (ZLAB) director adds 1,731 ADS in Rule 10b5-1 purchase - Stock Titan
Zai Lab (NASDAQ:ZLAB) Given New $32.00 Price Target at JPMorgan Chase & Co. - MarketBeat
Zai Lab to Present New Data on Three Internally Developed Oncology Candidates at AACR 2026, Including Zocilurtatug Pelitecan, a DLL3-Targeting Antibody-Drug Conjugate (ADC) - ChartMill
Zai Lab (NASDAQ:ZLAB) CFO Sells $31,726.89 in Stock - MarketBeat
Zai Lab (NASDAQ:ZLAB) Insider Joshua Smiley Sells 1,966 Shares - MarketBeat
Zai Lab (NASDAQ:ZLAB) Insider Sells $55,088.91 in Stock - MarketBeat
Zai Lab (ZLAB) officer granted options, RSUs and sells ADSs for taxes - Stock Titan
Zai Lab (ZLAB) CLO awarded major option, RSU grants and sells ADSs for taxes - Stock Titan
Zai Lab (NASDAQ: ZLAB) officer gets major equity grants, sells ADSs for taxes - Stock Titan
Zai Lab (ZLAB) CEO receives large ADS option and RSU grants - Stock Titan
Assessing Zai Lab (ZLAB) Valuation After Prolonged Share Price Weakness And Reported Intrinsic Discount - Sahm
ZLAB (NASDAQ: ZLAB) notice: 1,281 ADS proposed sale on 03/13/2026 - Stock Titan
Rafael Amado sells ZLAB ADS; 10,787 and 10,000 shares reported (ZLAB) - Stock Titan
Zai Lab Ltd (ADR) Stock (ISIN: CA98959U1084) Faces Insider Selling Pressure Amid Earnings Anticipati - AD HOC NEWS
[Form 4] Zai Lab Ltd Insider Trading Activity - Stock Titan
Zai Lab (NASDAQ: ZLAB) director files Form 144 to sell ADS - Stock Titan
Zai Lab (ZLAB) CEO exercises options and sells 100,000 ADS under 10b5-1 plan - Stock Titan
50,000 ADS sale flagged for ZLAB (NASDAQ: ZLAB) with recent Ying Du ADS sales - Stock Titan
Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Zai Lab (ZLAB) CEO trades 100K ADS under 10b5-1 plan - Stock Titan
0.49%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):